MedTrace Logo

IV vs IM Oxytocin in the Third Stage of Labor for Prevention of Postpartum Hemorrhage

NCT01608958 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 653

Last updated 2016-03-28

No results posted yet for this study

Summary

The study will evaluate whether prophylactic oxytocin administered in the third stage of labor via IV infusion results in a lower mean blood loss compared to IM injection.

Conditions

  • Postpartum Hemorrhage

Interventions

DRUG

Oxytocin

10 IU oxytocin in 500 ml infusion

DRUG

Oxytocin

10 IU oxytocin IM injection

Sponsors & Collaborators

  • Center for Research and Consultancy in Reproductive Health

    collaborator OTHER

  • Huong Vuong Hospital

    collaborator UNKNOWN

  • MOH Etlik Zubeyde Hanim Women's Health Training and Research Hospital

    collaborator UNKNOWN

  • Gynuity Health Projects

    lead OTHER

Principal Investigators

  • Beverly Winikoff, MD, MPH · Gynuity Health Projects

  • Ilana Dzuba, MHS · Gynuity Health Projects

  • Jill Durocher · Gynuity Health Projects

  • Jennifer Blum, MPH · Gynuity Health Projects

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2012-11-30
Completion
2012-12-31

Countries

  • Ecuador
  • Turkey (Türkiye)
  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01608958 on ClinicalTrials.gov